Gene Therapy

Correction: Genetic mutations in HSV-1 replication-defective vectors: Implications for their safety in gene therapy applications

by Biotech Newsroom
by Biotech Newsroom

Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Categories

Free Magazines

Quantum Computing for the Pharmaceutical Industry
 Get this free Magazine
Coronavirus: A Lesson on Exponentiation
 Get this free Magazine
CoreLogic Discusses the Role of Data Science in Prioritizing FinTech Market Entries
 Get this free Magazine
Reimagining HCP engagement
 Get this free Magazine
How to Build a Content Marketing Program at Scale: Six Must Have Components
 Get this free Magazine

Recent Articles

Three reasons why DeepSeek’s new model matters
OBGYN EHR Market Demand for Integrated Healthcare Systems
Organ-On-Chip Market Size to Expand at 29.63% CAGR, Reaching USD 1.85 Billion by 2031 Amid Regulatory Support
Medical Gloves Market to Reach USD 25.36 Billion by 2031 Driven by Infection Control and Rising Surgical Demand
Disposable Incontinence Products Market to Reach USD 22.01 Billion by 2031 Driven by Aging Population and Home-Care Demand
BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC